For more information, visit the company's web sites at http://www.thoratec.com or http://www.itcmed.com. Thoratec, the Thoratec logo, HeartMate and HeartMate II are registered trademarks of Thoratec Corporation and IVAD is a trademark of Thoratec Corporation. The company expects to incur incremental development costs of up to $3 million in 2010. Overall financial guidance for 2010 will be provided during the upcoming fourth quarter earnings call. This technology represents a compelling opportunity for Thoratec as we broaden our leadership position in MCS therapies